Monitoring bortezomib therapy in multiple myeloma: screening of cyclin D1, D2, and D3 via reliable real-time polymerase chain reaction and association with clinico-pathological features and outcome

Ba Thanh-Truc NgoDepartment of Hematology and Oncology, University Medical Center, Freiburg, Germany

Julia FelthausDepartment of Hematology and Oncology, University Medical Center, Freiburg, Germany

Manuel HeinDepartment of Hematology and Oncology, University Medical Center, Freiburg, Germany

Marie FolloCore Facility, University Medical Center, Freiburg, Germany

Dagmar WiderDepartment of Hematology and Oncology, University Medical Center, Freiburg, Germany

Gabriele IhorstCenter of Clinical Trials, University Medical Center, Freiburg, Germany

Monika EngelhardtDepartment of Hematology and Oncology, University Medical Center, Freiburg, Germany

Ralph WäschDepartment of Hematology and Oncology, University Medical Center, Freiburg, GermanyCorrespondence[email protected] or [email protected]

Your download is now in progress and you may close this window